Optimization of vaccine antigen for the development of improved influenza
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43IP001130
- Recipient
-
Najit Technologies, Inc. UEI MHB6EFN66MD9
- Awarding agency
-
Office of Financial Resources
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $224,171
Award facts
- Assistance listing
- 93.061 Innovations in Applied Public Health Research
- Completion date
- Funding agency
- National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention, Department of Health and Human Services
- Place of performance
- Beaverton, OR, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,171 |
Quick answers
Who received award R43IP001130?
R43IP001130 was awarded to Najit Technologies, Inc. by Office of Financial Resources (Centers for Disease Control and Prevention) on September 1, 2019.
How much is award R43IP001130 worth?
$224,171 has been obligated on R43IP001130.
Which agency awarded R43IP001130?
Office of Financial Resources (Centers for Disease Control and Prevention) awarded R43IP001130, with funding from National Center for Immunization and Respiratory Diseases (Centers for Disease Control and Prevention).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award